MedGenome: Felix Olale, Jennifer Rose, Amit Kakar
Felix Olale has been appointed as president and CEO and Jennifer Rose as executive VP and chief commercial officer of MedGenome.
Olale, previously chairman of MedGenome's board of directors, was most recently global co-lead of healthcare investments at LeapFrog Investments. Amit Kakar, managing partner and head of Novo Holdings Asia, will succeed him as chairman of MedGenome.
Rose was previously regional VP of business development at Precision for Medicine. She also held senior leadership roles at NeoGenomics Laboratories, GE Healthcare, PerkinElmer, and Thomson Reuters. She holds a master's degree in chemical engineering from the University of Connecticut and a bachelor's degree from Clemson University.